A Special Series for Cancer Awareness Month: Issues Facing the Jewish Community
As October in Cancer Awareness Month, we are partnering with Sharsheret, a national not-for-profit organization supporting young Jewish women and their families facing breast and other forms of cancer. We are thrilled to welcome medical experts from within our own Beth El family to openly discuss matters that far too often are reserved for the private realm, if addressed at all. Please join us in learning about issues facing the Jewish community and options for both prevention and treatment. All sessions are open to the public. Bring a friend – you might just save a life!
Caring for BRCA Carriers: Strategies to Promote Health and Preserve Fertility
Sunday, October 14 at 9:15 am
with Dr. Matthew Lederman, Reproductive Medicine Associates of New York
Understand BRCA and the Jewish Community. As BRCA carriers are faced with
complex challenges and need health care professionals to discuss not only the
medical implications of their carrier status and risk-reducing options, Dr. Lederman will present on the most up to date medical findings on fertility preservation and the use of Preimplantation Genetic Diagnosis (PGD) to prevent transmission to their offspring. After all, it is important for BRCA carriers to know that there are ways they can safely build a family. Please join us for this informative session.
Dr. Matthew Lederman is a board-certified Reproductive Endocrinologist and Infertility Specialist. He serves on the Medical Advisory Board of FORCE: Facing our Risk of Cancer Empowered, the Scientific Advisory Board for TEAL: Tell Every Amazing Lady About Ovarian Cancer and, is a fellow of the American College of Obstetricians and Gynecologists. He is a member of the American Society for Reproductive Medicine, Society of Reproductive Endocrinology and Infertility, Endocrine Society, Westchester OB/GYN Society, and Resolve. He has extensive clinical experience in all areas of fertility, including unexplained infertility, recurrent pregnancy loss, in vitro fertilization, egg freezing, preimplantation genetic screening and fertility preservation for patients recently diagnosed with cancer (oncofertility) and those who are predisposed to hereditary cancer syndromes (ie. BRCA).